GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Deltagen DGEN · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Deltagen — daily DGEN Delayed
Market value
$3,885
Last close × shares
Volume
443k
Shares, 30 Oct 2026

About Deltagen

Its shares trade under the ticker DGEN. It has been listed since 3 August 2000. In the fiscal year to 31 December 2015, it reported revenue of $770,000 and a net loss of $46,000. At that date it held total assets of $1.8m and shareholders' equity of $1.7m.

Deltagen, Inc. engages in the provision of drug discovery tools and services to the biopharmaceutical industry. The company is headquartered in San Mateo, California. The company went IPO on 2000-08-03. The firm offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The firm's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.

Figures and description from our data supplier, not checked against the company's own report.

More about Deltagen →

Latest on Deltagen

Our reporting

We have not reported on Deltagen yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Deltagen's ticker?

Deltagen trades as DGEN on its US listing, under ISIN US24783R1032.

What was Deltagen's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.